Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E P Frenkel

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
The Journal of Clinical Investigation|May 1, 1973
Abnormal fatty acid metabolism in peripheral nerves of patients with pernicious anemiaE P Frenkel
The American Journal of the Medical Sciences|May 1, 1993
Gaucher disease: a heterogeneous clinical complex for which effective enzyme replacement has come of ageE P Frenkel
The American Journal of the Medical Sciences|January 1, 1991
The clinical spectrum of thrombocytosis and thrombocythemiaE P Frenkel
Ophthalmology|December 21, 2016
Re: Brandt et al.: Human factors and ophthalmic drug packaging: time for a global standard (Ophthalmology 2015;122:2368-2370)Ronald E P Frenkel
Expert Opinion on Pharmacotherapy|May 5, 2001
Topoisomerase I inhibition with topotecan: pharmacologic and clinical issuesB Arun, E P Frenkel
Archives of Environmental Health|December 1, 1973
Percutaneous absorption and elimination of an aromatic hair dyeE P Frenkel, F Brody
Blood|March 1, 1972
Hereditary nonspherocytic hemolysis with erythrocyte phosphofructokinase deficiencyL Waterbury, E P Frenkel
In Vivo (Athens, Greece)|January 19, 1999
Issues of thrombosis and hemorrhagic events in patients with cancerE P Frenkel, R Bick
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 1, 1977
Comparative effects of methylmalonyl coenzyme A on fatty acid synthetase derived from rat and man (39895)E P Frenkel, R L Kitchens
Seminars in Thrombosis and Hemostasis|November 5, 1999
Prothrombin G20210A gene mutation, heparin cofactor II defects, primary (essential) thrombocythemia, and thrombohemorrhagic manifestationsE P Frenkel, R L Bick
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
The Journal of Clinical Investigation|May 1, 1973
Abnormal fatty acid metabolism in peripheral nerves of patients with pernicious anemiaE P Frenkel
The American Journal of the Medical Sciences|May 1, 1993
Gaucher disease: a heterogeneous clinical complex for which effective enzyme replacement has come of ageE P Frenkel
The American Journal of the Medical Sciences|January 1, 1991
The clinical spectrum of thrombocytosis and thrombocythemiaE P Frenkel
Ophthalmology|December 21, 2016
Re: Brandt et al.: Human factors and ophthalmic drug packaging: time for a global standard (Ophthalmology 2015;122:2368-2370)Ronald E P Frenkel
Expert Opinion on Pharmacotherapy|May 5, 2001
Topoisomerase I inhibition with topotecan: pharmacologic and clinical issuesB Arun, E P Frenkel
Archives of Environmental Health|December 1, 1973
Percutaneous absorption and elimination of an aromatic hair dyeE P Frenkel, F Brody
Blood|March 1, 1972
Hereditary nonspherocytic hemolysis with erythrocyte phosphofructokinase deficiencyL Waterbury, E P Frenkel
In Vivo (Athens, Greece)|January 19, 1999
Issues of thrombosis and hemorrhagic events in patients with cancerE P Frenkel, R Bick
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 1, 1977
Comparative effects of methylmalonyl coenzyme A on fatty acid synthetase derived from rat and man (39895)E P Frenkel, R L Kitchens
Seminars in Thrombosis and Hemostasis|November 5, 1999
Prothrombin G20210A gene mutation, heparin cofactor II defects, primary (essential) thrombocythemia, and thrombohemorrhagic manifestationsE P Frenkel, R L Bick
Pageof 14